VANGUARD GROUP INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$33,718,517
-28.1%
1,384,744
-0.2%
0.00%0.0%
Q1 2024$46,869,181
+1.9%
1,387,894
-4.8%
0.00%0.0%
Q4 2023$45,982,722
+27.9%
1,458,380
+3.7%
0.00%0.0%
Q3 2023$35,944,839
-23.0%
1,406,843
-13.6%
0.00%0.0%
Q2 2023$46,702,971
+33.0%
1,628,416
+11.1%
0.00%0.0%
Q1 2023$35,124,343
+42.8%
1,465,346
+1.0%
0.00%0.0%
Q4 2022$24,599,207
+24.2%
1,450,425
+8.5%
0.00%0.0%
Q3 2022$19,812,000
+5.5%
1,336,818
+12.0%
0.00%0.0%
Q2 2022$18,787,000
-39.6%
1,193,656
+3.5%
0.00%0.0%
Q1 2022$31,099,000
-26.8%
1,153,513
+0.5%
0.00%0.0%
Q4 2021$42,458,000
-20.2%
1,147,222
+3.0%
0.00%0.0%
Q3 2021$53,225,000
+33.3%
1,113,951
-5.6%
0.00%0.0%
Q2 2021$39,926,000
-19.3%
1,179,841
-1.5%
0.00%0.0%
Q1 2021$49,452,000
-3.6%
1,197,380
+1.3%
0.00%0.0%
Q4 2020$51,292,000
+15.3%
1,182,382
+14.0%
0.00%0.0%
Q3 2020$44,495,000
+9.3%
1,037,177
+19.1%
0.00%0.0%
Q2 2020$40,708,000
+1986.5%
870,935
+506.6%
0.00%
Q1 2020$1,951,000
+44.8%
143,581
+15.9%
0.00%
Q4 2019$1,347,000
+5.9%
123,8810.0%0.00%
Q3 2019$1,272,000123,8810.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Portolan Capital Management 484,907$11,807,4850.97%
Nikko Asset Management Americas, Inc. 1,563,065$37,966,8490.44%
Diametric Capital, LP 32,765$797,8270.43%
ARK Investment Management 1,964,964$47,846,8710.42%
SummerHaven Investment Management, LLC 23,400$569,7900.38%
Quantedge Capital Pte Ltd 40,800$993,4800.36%
Granahan Investment Management 344,549$8,389,7680.34%
FEDERATED HERMES, INC. 4,694,060$114,300,3610.27%
Belmont Capital, LLC 40,000$974,0000.18%
Woodline Partners LP 754,023$18,360,4600.18%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders